Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Geron Corporation
GERN | US
1.62
USD0.09
5.88%
GERN | US
Loading StockChartView...
About Geron Corporation
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
1.62
Open
1.50
High
1.63
Low
1.50
Geron Corporation a late-stage clinical biopharmaceutical company focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat a telomerase inhibitor that is in Phase 3 clinical trials which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. Geron Corporation was incorporated in 1990 and is headquartered in Foster City California.
View LessGERN | US
Risk
95.9
Sharpe
-0.16
Luna's Score
57/100
Recommendation
Hold
Luna says (GERN | US)
What's Working
Positive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
Smallcap (300M - 2B USD)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
112.7%1 month
95.9%3 months
73.2%6 months
63.6%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
8.04
Debt to equity
0.28
Debt to assets
0.19
Ent. to EBITDA
-9.06
Ent. to rev.
1.59K
PEG
-2.38
Other Fundamentals
EBITDA
-226.77M
MarketCap
976.53M
MarketCap(USD)
976.53M
Div. yield
-
Op. margin
-7.86K
Erngs. growth
-
Rev. growth
2.94K
Ret. on equity
-72.56
Short ratio
9.04
Short perc.
13.52
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.57
Range1M
0.61
Range3M
0.80
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.71
Price X volume
21.53M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -9.06 | 0.53 | Cheaper |
| Ent. to Revenue | 1,594.86 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 8.04 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 73.25 | 72.80 | Par |
| Debt to Equity | 0.28 | -1.23 | Expensive |
| Debt to Assets | 0.19 | 0.25 | Cheaper |
| Market Cap | 976.53M | 3.66B | Emerging |
